Page 2 - Clara Camp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clara camp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clara Camp Today - Breaking & Trending Today

The boom of the anti-aging market: How to get people to live to be 120 (and in good health)

This thriving industry which aims to reverse or delay age-related disease will be worth around $610 billion globally by 2025 ....

United States , Comunidad Autonoma De Aragon , Comunidad Autonoma De Cataluna , San Francisco , City Of , United Kingdom , Saudi Arabia , San Diego , Peter Thiel Paypal , Margaretta Colangelo , Marcp Bernegger , Mitrix Bio , Nouriel Roubini , Federico Pallard , Dmitry Kaminskiy , Richard Klausner , Hans Bishop , Felix Tran , Juan Carlos Izpis , Jeff Bezos , Sam Altman , Hal Barron , Sam Altman Chat , Alejo Rodr , Shinya Yamanaka , Mehmood Khan ,

20 years of BIOSPAIN

This year marks the 20th anniversary of BIOSPAIN. From September 26-28, 2023, BIOSPAIN will return to Barcelona, where it first started. ....

Comunidad Autonoma De Cataluna , Albert Castellanos , Spanish Bioindustry Association , Ion Arocena , Clara Camp , Asabys Partners ,

Catalonia health startup investments in 2022 top €296M to overtake 2021

Biocat says investment in startups in the Catalonia BioRegion is 2.5x higher than the same period last year, at €296M. ....

United States , Comunidad Autonoma De Cataluna , Joel Jean Mairet , Robert Fabregat , Barcelona City Council , Minoryx Therapeutics , Mangrove Capital , Alta Partners , Invivo Capital , Caixa Capital Risc , Clara Camp , Ysios Capital , Bioregion Report ,

Beyond Biotech podcast 2: Asabys, Asebio, MOA Foodtech

This week’s podcast is about Spain, with AseBio’s CEO, Ion Arocena; Clara Campàs, at Asabys, and Susana Sánchez Gómez from MOA Foodtech. ....

Spanish Bioindustry Association , European Bioindustry Association , Ion Arocena , Clara Camp ,

MedLumics closes upsized EUR 18M (21.7M USD) financing round and appoints new Chairman

Share this article
Share this article
MADRID, Feb. 10, 2021 /PRNewswire/ MedLumics, a privately held medical device company developing AblaView®, the first optically-guided real-time ablation catheter system for the treatment of Atrial Fibrillation (AF), announced today that it has closed an upsized EUR 18 million (USD 21.7 million) financing round and has appointed Rich Ferrari as Chairman of the Board of Directors. MedLumics optical catheter displays lesion creation in real-time providing the physician with direct visual confirmation of conduction tissue denaturation.
Kurma Partners joined the round which includes and was initially led by Asabys Partners, along with new investors, VI Partners Swiss Innovation and CDTI Innvierte Economía, and existing investors Andera Partners, Caixa Capital Risc and Innogest Capital II. Having achieved pre-clinical feasibility in 2020, these proceeds will now enable MedLumics to initiate first in-human regulatory clinical studie ....

Comunidad Autonoma De Cataluna , Comunidad Autonoma De Aragon , Olivier Litzka , Prnewswire Medlumics , James Greene , Peter Neubeck , Kurma Biofund , University Of South Florida , Medlumics Ireland Ltd , Sabadell Asabys Health Innovation Investments , European Fund For Strategic Investments , Its Life Sciences , Stanford Biodesign Emerging Entrepreneurs Forum , Stanford Coulter Foundation For Translational Medicine , Ashland University , European Union , Life Sciences , Vi Partners Swiss Innovation Fund , Atrial Fibrillation , Erich Ferrari , Asabys Partners , Swiss Innovation , Andera Partners , Caixa Capital Risc , Innogest Capital , Managing Director ,